Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Earnings
Invacare reports Q1 adjusted EPS (36c), consensus (33c) » 16:26
05/05/21
05/05
16:26
05/05/21
16:26
IVC

Invacare

$8.89 /

-0.065 (-0.73%)

Reports Q1 revenue…

Reports Q1 revenue $196.2M, consensus $203.67M. Commenting on 1Q21 results, Matt Monaghan, chairman, president, and chief executive officer, said "We entered 2021 with strong demand for lifestyle and respiratory products and strengthening demand for mobility & seating products. We see these trends continuing into the second quarter. Despite good demand, our first quarter revenues were lower by approximately $15 million of firm orders which didn't ship and become revenue in the quarter as a result of various supply chain disruptions, which impacted all regions. Component delays and parts shortages prevented the timely delivery of confirmed orders and led to a higher than typical backlog, with the additional backlog expected to convert to net sales within the next two quarters. As our team continues to rise to the challenge of supporting our customers globally, we will mitigate further disruptions by investing in additional inventory in the short-term."

ShowHide Related Items >><<
IVC Invacare
$8.89 /

-0.065 (-0.73%)

IVC Invacare
$8.89 /

-0.065 (-0.73%)

Conference/Events
Needham to hold a virtual conference » 09:12
04/12/21
04/12
09:12
04/12/21
09:12
GRCL

Gracell

$13.52 /

-0.82 (-5.72%)

, LMAT

LeMaitre

$51.38 /

+0.82 (+1.62%)

, IONS

Ionis Pharmaceuticals

$42.32 /

-0.32 (-0.75%)

, TSHA

Taysha Gene Therapies

$21.35 /

+1.49 (+7.50%)

, ZEAL

Zealand Pharma

$33.60 /

+1.27 (+3.93%)

, CLSD

Clearside Biomedical

$2.66 /

+0.12 (+4.72%)

, MEIP

MEI Pharma

$3.43 /

+0.12 (+3.63%)

, PCVX

Vaxcyte

$20.27 /

-0.49 (-2.36%)

, EVLO

Evelo Biosciences

$10.03 /

+0.005 (+0.05%)

, IVC

Invacare

$8.23 /

-0.08 (-0.96%)

, BSGM

BioSig Technologies

$4.59 /

+0.12 (+2.68%)

, CYTK

Cytokinetics

$24.17 /

+0.01 (+0.04%)

, SYBX

Synlogic

$3.34 /

-0.02 (-0.60%)

, RNA

Avidity Biosciences

$22.12 /

-1.8 (-7.53%)

, CSTL

Castle Biosciences

$69.44 /

-1.2 (-1.70%)

, AGI

Alamos Gold

$8.37 /

+0.08 (+0.97%)

, CARA

Cara Therapeutics

$29.09 /

+1.645 (+5.99%)

, FIX

Comfort Systems USA

$79.11 /

+1.925 (+2.49%)

, ITRM

Iterum Therapeutics

$1.30 /

-0.305 (-19.00%)

, LTRN

Lantern Pharma

$17.05 /

-0.13 (-0.76%)

, OCGN

Ocugen

$6.96 /

+0.045 (+0.65%)

, QURE

uniQure

$33.77 /

-1.75 (-4.93%)

, STTK

Shattuck Labs

$28.31 /

+1.365 (+5.07%)

, VKTX

Viking Therapeutics

$5.93 /

-0.23 (-3.73%)

20th Annual Virtual…

20th Annual Virtual Healthcare Virtual Conference will be held on April 12-15.

ShowHide Related Items >><<
ZEAL Zealand Pharma
$33.60 /

+1.27 (+3.93%)

VKTX Viking Therapeutics
$5.93 /

-0.23 (-3.73%)

TSHA Taysha Gene Therapies
$21.35 /

+1.49 (+7.50%)

SYBX Synlogic
$3.34 /

-0.02 (-0.60%)

STTK Shattuck Labs
$28.31 /

+1.365 (+5.07%)

RNA Avidity Biosciences
$22.12 /

-1.8 (-7.53%)

QURE uniQure
$33.77 /

-1.75 (-4.93%)

PCVX Vaxcyte
$20.27 /

-0.49 (-2.36%)

OCGN Ocugen
$6.96 /

+0.045 (+0.65%)

MEIP MEI Pharma
$3.43 /

+0.12 (+3.63%)

LTRN Lantern Pharma
$17.05 /

-0.13 (-0.76%)

LMAT LeMaitre
$51.38 /

+0.82 (+1.62%)

IVC Invacare
$8.23 /

-0.08 (-0.96%)

ITRM Iterum Therapeutics
$1.30 /

-0.305 (-19.00%)

IONS Ionis Pharmaceuticals
$42.32 /

-0.32 (-0.75%)

GRCL Gracell
$13.52 /

-0.82 (-5.72%)

FIX Comfort Systems USA
$79.11 /

+1.925 (+2.49%)

EVLO Evelo Biosciences
$10.03 /

+0.005 (+0.05%)

CYTK Cytokinetics
$24.17 /

+0.01 (+0.04%)

CSTL Castle Biosciences
$69.44 /

-1.2 (-1.70%)

CLSD Clearside Biomedical
$2.66 /

+0.12 (+4.72%)

CARA Cara Therapeutics
$29.09 /

+1.645 (+5.99%)

BSGM BioSig Technologies
$4.59 /

+0.12 (+2.68%)

AGI Alamos Gold
$8.37 /

+0.08 (+0.97%)

GRCL Gracell
$13.52 /

-0.82 (-5.72%)

02/03/21 Citi
Gracell initiated with a Buy at Citi
02/02/21 Jefferies
Gracell initiated with a Buy at Jefferies
02/02/21 Wells Fargo
Gracell initiated with an Overweight at Wells Fargo
02/02/21 Piper Sandler
Gracell initiated with an Overweight at Piper Sandler
LMAT LeMaitre
$51.38 /

+0.82 (+1.62%)

02/26/21 Barrington
LeMaitre price target raised to $49 from $47 at Barrington
02/12/21
Fly Intel: Top five analyst initiations
02/12/21 KeyBanc
LeMaitre initiated with a Sector Weight at KeyBanc
02/11/21 KeyBanc
LeMaitre initiated with a Sector Weight at KeyBanc
IONS Ionis Pharmaceuticals
$42.32 /

-0.32 (-0.75%)

03/29/21 Piper Sandler
Ionis' Phase 2 data for PKK-LRx 'impressive' at face value, says Piper Sandler
03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform at RBC Capital on valuation
03/23/21 Truist
Truist sees mixed readthroughs to Wave's toplines from competitor HD setback
03/23/21 BMO Capital
Ionis Pharmaceuticals price target lowered to $76 from $90 at BMO Capital
TSHA Taysha Gene Therapies
$21.35 /

+1.49 (+7.50%)

03/04/21 Chardan
Taysha Gene Therapies price target raised to $60 from $45 at Chardan
02/23/21 William Blair
William Blair starts Taysha with Outperform, $46 fair-value estimate
02/23/21 William Blair
William Blair starts Taysha Gene Therapies with Outperform on positive FDA draft
02/23/21 William Blair
Taysha Gene Therapies initiated with an Outperform at William Blair
ZEAL Zealand Pharma
$33.60 /

+1.27 (+3.93%)

CLSD Clearside Biomedical
$2.66 /

+0.12 (+4.72%)

03/02/21 Roth Capital
Clearside enrollment speed 'encouraging,' says Roth Capital
12/03/20 Roth Capital
Clearside platform validated by Janssen deal, says Roth Capital
08/06/20 Roth Capital
Investors should buy 'highly undervalued' Clearside, says Roth Capital
06/19/20 Roth Capital
Clearside Biomedical abstracts highlight strength, says Roth Capital
MEIP MEI Pharma
$3.43 /

+0.12 (+3.63%)

10/12/20 Brookline
MEI Pharma initiated with a Buy at Brookline
09/22/20 Alliance Global Partners
MEI Pharma initiated with a Buy at Alliance Global Partners
07/06/20 Truist
MEI Pharma price target lowered to $12 from $16 at SunTrust
05/29/20
Fly Intel: Top five analyst initiations
PCVX Vaxcyte
$20.27 /

-0.49 (-2.36%)

07/16/20 Wells Fargo
Sutro Biopharma initiated with an Overweight at Wells Fargo
07/07/20
Fly Intel: Top five analyst initiations
07/07/20 BofA
Vaxcyte initiated with a Buy at BofA
07/07/20 Jefferies
Vaxcyte initiated with a Buy at Jefferies
EVLO Evelo Biosciences
$10.03 /

+0.005 (+0.05%)

04/12/21 Jefferies
Jefferies upgrades Evelo Biosciences to Buy on increased microbiome momentum
04/12/21 Jefferies
Evelo Biosciences upgraded to Buy from Hold at Jefferies
03/12/21 Chardan
Evelo Biosciences price target raised to $15 from $10 at Chardan
01/25/21 JMP Securities
Evelo Biosciences price target raised to $36 from $27 at JMP Securities
IVC Invacare
$8.23 /

-0.08 (-0.96%)

BSGM BioSig Technologies
$4.59 /

+0.12 (+2.68%)

CYTK Cytokinetics
$24.17 /

+0.01 (+0.04%)

03/11/21 Wolfe Research
Cytokinetics initiated with an Outperform at Wolfe Research
02/18/21 Barclays
Cytokinetics initiated with an Overweight at Barclays
01/20/21 H.C. Wainwright
Cytokinetics price target raised to $41 from $22 at H.C. Wainwright
12/28/20 Oppenheimer
Amgen price target lowered to $266 from $274 at Oppenheimer
SYBX Synlogic
$3.34 /

-0.02 (-0.60%)

03/25/21 SVB Leerink
Synlogic price target raised to $15 from $10 at SVB Leerink
03/18/21 JonesTrading
Synlogic initiated with a Buy at JonesTrading
01/13/21 Chardan
Chardan doubles Synlogic target to $10, names top 2021 pick
09/18/20 Chardan
Seres Therapeutics downgraded to Neutral from Buy at Chardan
RNA Avidity Biosciences
$22.12 /

-1.8 (-7.53%)

07/07/20 Cowen
Avidity Biosciences initiated with an Outperform at Cowen
07/07/20 SVB Leerink
Avidity Biosciences initiated with an Outperform at SVB Leerink
07/07/20 Cowen
Avidity Biosciences initiated with an Outperform at Cowen
07/07/20 Wells Fargo
Avidity Biosciences initiated with an Overweight at Wells Fargo
CSTL Castle Biosciences
$69.44 /

-1.2 (-1.70%)

03/09/21 Baird
Castle Biosciences price target lowered to $82 from $87 at Baird
02/03/21 KeyBanc
Castle Biosciences price target raised to $90 from $70 at KeyBanc
01/26/21 Canaccord
Castle Biosciences price target raised to $84 from $80 at Canaccord
01/15/21 SVB Leerink
Castle Biosciences price target raised to $80 from $70 at SVB Leerink
AGI Alamos Gold
$8.37 /

+0.08 (+0.97%)

02/10/21 JPMorgan
Alamos Gold initiated with a Neutral at JPMorgan
02/08/21 CIBC
Alamos Gold price target lowered to C$16 from C$19.25 at CIBC
02/02/21 National Bank
Alamos Gold price target lowered to C$14.50 from C$15.50 at National Bank
01/11/21 National Bank
Alamos Gold price target lowered to C$15.50 from C$16 at National Bank
CARA Cara Therapeutics
$29.09 /

+1.645 (+5.99%)

12/29/20 H.C. Wainwright
H.C. Wainwright reiterates $33 target on Cara after new drug filing
10/20/20 H.C. Wainwright
Cara deal with 'perfect partner' Vifor boosts confidence at H.C. Wainwright
04/22/20 Cantor Fitzgerald
Cara Therapeutics price target raised to $34 from $26 at Cantor Fitzgerald
04/21/20 H.C. Wainwright
Cara Therapeutics price target raised to $33 from $30 at H.C. Wainwright
FIX Comfort Systems USA
$79.11 /

+1.925 (+2.49%)

07/29/20 DA Davidson
Comfort Systems USA price target raised to $45 from $32 at DA Davidson
04/29/20 DA Davidson
Comfort Systems USA downgraded to Neutral from Buy at DA Davidson
04/29/20 DA Davidson
Comfort Systems USA downgraded to Neutral from Buy at DA Davidson
04/20/20 Sidoti
Comfort Systems USA downgraded to Neutral from Buy at Sidoti
ITRM Iterum Therapeutics
$1.30 /

-0.305 (-19.00%)

03/15/21 H.C. Wainwright
Iterum Therapeutics upgraded to Buy from Neutral at H.C. Wainwright
12/24/20 H.C. Wainwright
Iterum CSO resignation 'somewhat troubling,' says H.C. Wainwright
06/16/20 H.C. Wainwright
Iterum Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
06/02/20 RBC Capital
Iterum Therapeutics downgraded to Sector Perform from Outperform at RBC Capital
LTRN Lantern Pharma
$17.05 /

-0.13 (-0.76%)

08/10/20 ThinkEquity
Lantern Pharma initiated with a Buy at ThinkEquity
07/28/20 Colliers
Drug 'rescuer' Lantern Pharma started at Buy at Colliers
07/28/20 Colliers
Lantern Pharma initiated with a Buy at Colliers
OCGN Ocugen
$6.96 /

+0.045 (+0.65%)

03/31/21
Ocugen participates in a conference call with Cantor Fitzgerald
03/16/21 Roth Capital
Covaxin chances of U.S. approval now increased, says Roth Capital
03/04/21 Roth Capital
Ocugen price target raised to $10 from $9 at Roth Capital
03/04/21 Roth Capital
Roth boosts Ocugen target after partnered vaccine shows 'broad' efficacy
QURE uniQure
$33.77 /

-1.75 (-4.93%)

04/01/21
Fly Intel: Top five analyst upgrades
04/01/21 Mizuho
uniQure upgraded to Buy on favorable risk/reward at Mizuho
04/01/21 Mizuho
uniQure upgraded to Buy from Neutral at Mizuho
03/29/21 H.C. Wainwright
uniQure probe 'important first step' toward lifting hold, says H.C. Wainwright
STTK Shattuck Labs
$28.31 /

+1.365 (+5.07%)

01/20/21 Citi
Shattuck Labs price target raised to $75 from $36 at Citi
01/11/21 Evercore ISI
Shattuck Labs initiated with an Outperform at Evercore ISI
11/03/20 Needham
Shattuck Labs initiated with a Buy at Needham
11/03/20 Citi
Shattuck Labs initiated with a Buy at Citi
VKTX Viking Therapeutics
$5.93 /

-0.23 (-3.73%)

02/18/21 Chardan
Chardan trims Viking Therapeutics target to $19 as COVID pushes out Voyage data
09/11/20 B. Riley
Viking Therapeutics price target raised to $15 from $12 at B. Riley FBR
09/01/20 BTIG
Viking Therapeutics price target raised to $12 from $9 at BTIG
08/30/20 Chardan
Viking Therapeutics price target raised to $20 from $15 at Chardan
ZEAL Zealand Pharma
$33.60 /

+1.27 (+3.93%)

VKTX Viking Therapeutics
$5.93 /

-0.23 (-3.73%)

TSHA Taysha Gene Therapies
$21.35 /

+1.49 (+7.50%)

SYBX Synlogic
$3.34 /

-0.02 (-0.60%)

STTK Shattuck Labs
$28.31 /

+1.365 (+5.07%)

RNA Avidity Biosciences
$22.12 /

-1.8 (-7.53%)

QURE uniQure
$33.77 /

-1.75 (-4.93%)

PCVX Vaxcyte
$20.27 /

-0.49 (-2.36%)

OCGN Ocugen
$6.96 /

+0.045 (+0.65%)

MEIP MEI Pharma
$3.43 /

+0.12 (+3.63%)

LTRN Lantern Pharma
$17.05 /

-0.13 (-0.76%)

LMAT LeMaitre
$51.38 /

+0.82 (+1.62%)

IVC Invacare
$8.23 /

-0.08 (-0.96%)

ITRM Iterum Therapeutics
$1.30 /

-0.305 (-19.00%)

IONS Ionis Pharmaceuticals
$42.32 /

-0.32 (-0.75%)

FIX Comfort Systems USA
$79.11 /

+1.925 (+2.49%)

EVLO Evelo Biosciences
$10.03 /

+0.005 (+0.05%)

CYTK Cytokinetics
$24.17 /

+0.01 (+0.04%)

CSTL Castle Biosciences
$69.44 /

-1.2 (-1.70%)

CLSD Clearside Biomedical
$2.66 /

+0.12 (+4.72%)

CARA Cara Therapeutics
$29.09 /

+1.645 (+5.99%)

AGI Alamos Gold
$8.37 /

+0.08 (+0.97%)

  • 29
    Jan
  • 15
    Jan
  • 08
    Jan
  • 16
    Dec
  • 09
    Oct
  • 24
    Sep
  • 17
    Jul
  • 25
    Jun
  • 25
    Jun
  • 11
    Jun
  • 12
    Jun
  • 12
    Jun
OCGN Ocugen
$6.96 /

+0.045 (+0.65%)

SYBX Synlogic
$3.34 /

-0.02 (-0.60%)

QURE uniQure
$33.77 /

-1.75 (-4.93%)

PCVX Vaxcyte
$20.27 /

-0.49 (-2.36%)

OCGN Ocugen
$6.96 /

+0.045 (+0.65%)

MEIP MEI Pharma
$3.43 /

+0.12 (+3.63%)

ITRM Iterum Therapeutics
$1.30 /

-0.305 (-19.00%)

IONS Ionis Pharmaceuticals
$42.32 /

-0.32 (-0.75%)

GRCL Gracell
$13.52 /

-0.82 (-5.72%)

FIX Comfort Systems USA
$79.11 /

+1.925 (+2.49%)

CSTL Castle Biosciences
$69.44 /

-1.2 (-1.70%)

CARA Cara Therapeutics
$29.09 /

+1.645 (+5.99%)

AGI Alamos Gold
$8.37 /

+0.08 (+0.97%)

PCVX Vaxcyte
$20.27 /

-0.49 (-2.36%)

OCGN Ocugen
$6.96 /

+0.045 (+0.65%)

IONS Ionis Pharmaceuticals
$42.32 /

-0.32 (-0.75%)

EVLO Evelo Biosciences
$10.03 /

+0.005 (+0.05%)

CYTK Cytokinetics
$24.17 /

+0.01 (+0.04%)

BSGM BioSig Technologies
$4.59 /

+0.12 (+2.68%)

AGI Alamos Gold
$8.37 /

+0.08 (+0.97%)

Conference/Events
KeyBanc Capital Markets to hold a virtual forum » 04:55
03/24/21
03/24
04:55
03/24/21
04:55
INGN

Inogen

$47.52 /

-1.8 (-3.65%)

, RMD

ResMed

$190.70 /

+1.12 (+0.59%)

, HRC

Hill-Rom

$107.07 /

-1.77 (-1.63%)

, ENZ

Enzo Biochem

$3.50 /

-0.27 (-7.16%)

, ICUI

ICU Medical

$207.63 /

+0.75 (+0.36%)

, RCM

R1 RCM

$25.12 /

-0.14 (-0.55%)

, CNMD

Conmed

$122.08 /

-3.14 (-2.51%)

, MRVI

Maravai Lifesciences

$36.44 /

-0.49 (-1.33%)

, PINC

Premier

$33.32 /

-0.16 (-0.48%)

, BRKS

Brooks Automation

$78.43 /

-9.91 (-11.22%)

, IVC

Invacare

$8.03 /

-0.47 (-5.53%)

, AVNS

Avanos

$44.38 /

-0.75 (-1.66%)

Life Sciences &…

Life Sciences & MedTech Investor Virtual Forum to be held on March 23-24.

ShowHide Related Items >><<
RCM R1 RCM
$25.12 /

-0.14 (-0.55%)

PINC Premier
$33.32 /

-0.16 (-0.48%)

MRVI Maravai Lifesciences
$36.44 /

-0.49 (-1.33%)

IVC Invacare
$8.03 /

-0.47 (-5.53%)

INGN Inogen
$47.52 /

-1.8 (-3.65%)

HRC Hill-Rom
$107.07 /

-1.77 (-1.63%)

ENZ Enzo Biochem
$3.50 /

-0.27 (-7.16%)

CNMD Conmed
$122.08 /

-3.14 (-2.51%)

BRKS Brooks Automation
$78.43 /

-9.91 (-11.22%)

INGN Inogen
$47.52 /

-1.8 (-3.65%)

12/14/20 KeyBanc
Inogen upgraded to Overweight after management meetings at KeyBanc
12/14/20 KeyBanc
Inogen upgraded to Overweight from Sector Weight at KeyBanc
07/23/20
Fly Intel: Top five analyst downgrades
07/23/20 Needham
Needham downgrades Inogen to Hold on concerns over DTC business
RMD ResMed
$190.70 /

+1.12 (+0.59%)

03/16/21 Needham
ResMed upgraded to Buy from Hold at Needham
03/16/21 Needham
ResMed upgraded to Buy from Hold at Needham
10/30/20 JPMorgan
ResMed upgraded to Neutral on sleep sector recovery at JPMorgan
10/30/20 Credit Suisse
ResMed upgraded to Outperform from Neutral at Credit Suisse
HRC Hill-Rom
$107.07 /

-1.77 (-1.63%)

02/08/21 Baird
Hill-Rom price target raised to $115 from $105 at Baird
01/25/21 Morgan Stanley
iRhythm price target raised to $288 from $227 at Morgan Stanley
11/04/20
Fly Intel: Top five analyst downgrades
11/04/20
Hill-Rom cut to Hold at Needham, expecting 'lost year' in FY21
ENZ Enzo Biochem
$3.50 /

-0.27 (-7.16%)

ICUI ICU Medical
$207.63 /

+0.75 (+0.36%)

09/02/20 KeyBanc
ICU Medical price target raised to $218 from $199 at KeyBanc
05/13/20 KeyBanc
ICU Medical price target lowered to $199 from $206 at KeyBanc
RCM R1 RCM
$25.12 /

-0.14 (-0.55%)

02/16/21 KeyBanc
R1 RCM price target raised to $35 from $27 at KeyBanc
02/09/21 Cowen
R1 RCM price target raised to $33 from $22 at Cowen
01/08/21 Baird
Vocera downgraded to Neutral on valuation at Baird
12/09/20 RBC Capital
R1 RCM price target raised to $27 from $20 at RBC Capital
CNMD Conmed
$122.08 /

-3.14 (-2.51%)

01/28/21 Piper Sandler
Conmed price target raised to $145 from $95 at Piper Sandler
09/30/20 Piper Sandler
Piper Sandler 'highly' recommends five names in Medical Technology
07/29/20 Piper Sandler
Conmed price target raised to $95 from $90 at Piper Sandler
04/30/20 Piper Sandler
Conmed price target lowered to $90 from $110 at Piper Sandler
MRVI Maravai Lifesciences
$36.44 /

-0.49 (-1.33%)

03/03/21 Morgan Stanley
Maravai Lifesciences price target raised to $54 from $35 at Morgan Stanley
03/03/21 KeyBanc
Maravai Lifesciences price target raised to $46 from $39 at KeyBanc
03/03/21 Credit Suisse
Maravai Lifesciences price target raised to $42 from $34 at Credit Suisse
02/10/21 KeyBanc
Maravai Lifesciences price target raised to $39 from $33 at KeyBanc
PINC Premier
$33.32 /

-0.16 (-0.48%)

02/04/21 Piper Sandler
Premier price target raised to $36 from $32 at Piper Sandler
02/04/21 Truist
Premier price target raised to $38 from $33 at Truist
02/03/21 Benchmark
Premier upgraded to Buy from Hold at Benchmark
01/19/21 BofA
Premier double-downgraded to Underperform from Buy at BofA
BRKS Brooks Automation
$78.43 /

-9.91 (-11.22%)

02/10/21 KeyBanc
Brooks Automation price target raised to $111 from $99 at KeyBanc
02/03/21 Credit Suisse
Brooks Automation price target raised to $70 from $58 at Credit Suisse
02/03/21 B. Riley
Brooks Automation price target raised to $105 from $100 at B. Riley Securities
02/03/21 KeyBanc
Brooks Automation price target raised to $99 from $75 at KeyBanc
IVC Invacare
$8.03 /

-0.47 (-5.53%)

AVNS Avanos
$44.38 /

-0.75 (-1.66%)

04/13/20 Barclays
Avanos upgraded to Equal Weight from Underweight at Barclays
RMD ResMed
$190.70 /

+1.12 (+0.59%)

RCM R1 RCM
$25.12 /

-0.14 (-0.55%)

PINC Premier
$33.32 /

-0.16 (-0.48%)

MRVI Maravai Lifesciences
$36.44 /

-0.49 (-1.33%)

IVC Invacare
$8.03 /

-0.47 (-5.53%)

INGN Inogen
$47.52 /

-1.8 (-3.65%)

ICUI ICU Medical
$207.63 /

+0.75 (+0.36%)

HRC Hill-Rom
$107.07 /

-1.77 (-1.63%)

ENZ Enzo Biochem
$3.50 /

-0.27 (-7.16%)

CNMD Conmed
$122.08 /

-3.14 (-2.51%)

BRKS Brooks Automation
$78.43 /

-9.91 (-11.22%)

AVNS Avanos
$44.38 /

-0.75 (-1.66%)

  • 20
    Nov
RMD ResMed
$190.70 /

+1.12 (+0.59%)

MRVI Maravai Lifesciences
$36.44 /

-0.49 (-1.33%)

INGN Inogen
$47.52 /

-1.8 (-3.65%)

ENZ Enzo Biochem
$3.50 /

-0.27 (-7.16%)

CNMD Conmed
$122.08 /

-3.14 (-2.51%)

BRKS Brooks Automation
$78.43 /

-9.91 (-11.22%)

RMD ResMed
$190.70 /

+1.12 (+0.59%)

MRVI Maravai Lifesciences
$36.44 /

-0.49 (-1.33%)

ENZ Enzo Biochem
$3.50 /

-0.27 (-7.16%)

Over a quarter ago
Conference/Events
KeyBanc Capital Markets to hold a virtual forum » 10:19
03/23/21
03/23
10:19
03/23/21
10:19
INGN

Inogen

$48.29 /

-1.03 (-2.09%)

, RMD

ResMed

$190.03 /

+0.45 (+0.24%)

, HRC

Hill-Rom

$107.37 /

-1.47 (-1.35%)

, ENZ

Enzo Biochem

$3.60 /

-0.17 (-4.51%)

, ICUI

ICU Medical

$208.87 /

+1.99 (+0.96%)

, RCM

R1 RCM

$24.92 /

-0.34 (-1.35%)

, CNMD

Conmed

$122.66 /

-2.56 (-2.04%)

, MRVI

Maravai Lifesciences

$36.38 /

-0.55 (-1.49%)

, PINC

Premier

$33.29 /

-0.19 (-0.57%)

, BRKS

Brooks Automation

$86.00 /

-2.34 (-2.65%)

, IVC

Invacare

$8.32 /

-0.18 (-2.12%)

, AVNS

Avanos

$44.65 /

-0.48 (-1.06%)

Life Sciences &…

Life Sciences & MedTech Investor Virtual Forum to be held on March 23-24.

ShowHide Related Items >><<
RCM R1 RCM
$24.92 /

-0.34 (-1.35%)

PINC Premier
$33.29 /

-0.19 (-0.57%)

MRVI Maravai Lifesciences
$36.38 /

-0.55 (-1.49%)

IVC Invacare
$8.32 /

-0.18 (-2.12%)

INGN Inogen
$48.29 /

-1.03 (-2.09%)

HRC Hill-Rom
$107.37 /

-1.47 (-1.35%)

ENZ Enzo Biochem
$3.60 /

-0.17 (-4.51%)

CNMD Conmed
$122.66 /

-2.56 (-2.04%)

BRKS Brooks Automation
$86.00 /

-2.34 (-2.65%)

INGN Inogen
$48.29 /

-1.03 (-2.09%)

12/14/20 KeyBanc
Inogen upgraded to Overweight after management meetings at KeyBanc
12/14/20 KeyBanc
Inogen upgraded to Overweight from Sector Weight at KeyBanc
07/23/20
Fly Intel: Top five analyst downgrades
07/23/20 Needham
Needham downgrades Inogen to Hold on concerns over DTC business
RMD ResMed
$190.03 /

+0.45 (+0.24%)

03/16/21 Needham
ResMed upgraded to Buy from Hold at Needham
03/16/21 Needham
ResMed upgraded to Buy from Hold at Needham
10/30/20 JPMorgan
ResMed upgraded to Neutral on sleep sector recovery at JPMorgan
10/30/20 Credit Suisse
ResMed upgraded to Outperform from Neutral at Credit Suisse
HRC Hill-Rom
$107.37 /

-1.47 (-1.35%)

02/08/21 Baird
Hill-Rom price target raised to $115 from $105 at Baird
01/25/21 Morgan Stanley
iRhythm price target raised to $288 from $227 at Morgan Stanley
11/04/20
Fly Intel: Top five analyst downgrades
11/04/20
Hill-Rom cut to Hold at Needham, expecting 'lost year' in FY21
ENZ Enzo Biochem
$3.60 /

-0.17 (-4.51%)

ICUI ICU Medical
$208.87 /

+1.99 (+0.96%)

09/02/20 KeyBanc
ICU Medical price target raised to $218 from $199 at KeyBanc
05/13/20 KeyBanc
ICU Medical price target lowered to $199 from $206 at KeyBanc
RCM R1 RCM
$24.92 /

-0.34 (-1.35%)

02/16/21 KeyBanc
R1 RCM price target raised to $35 from $27 at KeyBanc
02/09/21 Cowen
R1 RCM price target raised to $33 from $22 at Cowen
01/08/21 Baird
Vocera downgraded to Neutral on valuation at Baird
12/09/20 RBC Capital
R1 RCM price target raised to $27 from $20 at RBC Capital
CNMD Conmed
$122.66 /

-2.56 (-2.04%)

01/28/21 Piper Sandler
Conmed price target raised to $145 from $95 at Piper Sandler
09/30/20 Piper Sandler
Piper Sandler 'highly' recommends five names in Medical Technology
07/29/20 Piper Sandler
Conmed price target raised to $95 from $90 at Piper Sandler
04/30/20 Piper Sandler
Conmed price target lowered to $90 from $110 at Piper Sandler
MRVI Maravai Lifesciences
$36.38 /

-0.55 (-1.49%)

03/03/21 Morgan Stanley
Maravai Lifesciences price target raised to $54 from $35 at Morgan Stanley
03/03/21 KeyBanc
Maravai Lifesciences price target raised to $46 from $39 at KeyBanc
03/03/21 Credit Suisse
Maravai Lifesciences price target raised to $42 from $34 at Credit Suisse
02/10/21 KeyBanc
Maravai Lifesciences price target raised to $39 from $33 at KeyBanc
PINC Premier
$33.29 /

-0.19 (-0.57%)

02/04/21 Piper Sandler
Premier price target raised to $36 from $32 at Piper Sandler
02/04/21 Truist
Premier price target raised to $38 from $33 at Truist
02/03/21 Benchmark
Premier upgraded to Buy from Hold at Benchmark
01/19/21 BofA
Premier double-downgraded to Underperform from Buy at BofA
BRKS Brooks Automation
$86.00 /

-2.34 (-2.65%)

02/10/21 KeyBanc
Brooks Automation price target raised to $111 from $99 at KeyBanc
02/03/21 Credit Suisse
Brooks Automation price target raised to $70 from $58 at Credit Suisse
02/03/21 B. Riley
Brooks Automation price target raised to $105 from $100 at B. Riley Securities
02/03/21 KeyBanc
Brooks Automation price target raised to $99 from $75 at KeyBanc
IVC Invacare
$8.32 /

-0.18 (-2.12%)

AVNS Avanos
$44.65 /

-0.48 (-1.06%)

04/13/20 Barclays
Avanos upgraded to Equal Weight from Underweight at Barclays
RMD ResMed
$190.03 /

+0.45 (+0.24%)

RCM R1 RCM
$24.92 /

-0.34 (-1.35%)

PINC Premier
$33.29 /

-0.19 (-0.57%)

MRVI Maravai Lifesciences
$36.38 /

-0.55 (-1.49%)

IVC Invacare
$8.32 /

-0.18 (-2.12%)

INGN Inogen
$48.29 /

-1.03 (-2.09%)

ICUI ICU Medical
$208.87 /

+1.99 (+0.96%)

HRC Hill-Rom
$107.37 /

-1.47 (-1.35%)

ENZ Enzo Biochem
$3.60 /

-0.17 (-4.51%)

CNMD Conmed
$122.66 /

-2.56 (-2.04%)

BRKS Brooks Automation
$86.00 /

-2.34 (-2.65%)

AVNS Avanos
$44.65 /

-0.48 (-1.06%)

  • 20
    Nov
RMD ResMed
$190.03 /

+0.45 (+0.24%)

MRVI Maravai Lifesciences
$36.38 /

-0.55 (-1.49%)

INGN Inogen
$48.29 /

-1.03 (-2.09%)

ENZ Enzo Biochem
$3.60 /

-0.17 (-4.51%)

CNMD Conmed
$122.66 /

-2.56 (-2.04%)

BRKS Brooks Automation
$86.00 /

-2.34 (-2.65%)

RMD ResMed
$190.03 /

+0.45 (+0.24%)

MRVI Maravai Lifesciences
$36.38 /

-0.55 (-1.49%)

ENZ Enzo Biochem
$3.60 /

-0.17 (-4.51%)

Conference/Events
Morgan Stanley to hold a virtual conference » 10:12
03/16/21
03/16
10:12
03/16/21
10:12
ALEC

Alector

$18.70 /

+0.05 (+0.27%)

, AVRO

Avrobio

$13.36 /

+0.34 (+2.61%)

, BOLT

Bolt Biotherapeutics

$39.81 /

+0.99 (+2.55%)

, CABA

Cabaletta Bio

$11.81 /

-0.01 (-0.08%)

, FHTX

Foghorn Therapeutics

$12.71 /

+0.1 (+0.79%)

, FULC

Fulcrum Therapeutics

$11.91 /

-0.06 (-0.50%)

, FUSN

Fusion Pharmaceuticals

$11.70 /

-0.05 (-0.43%)

, HAE

Haemonetics

$118.72 /

-0.44 (-0.37%)

, IMRA

Imara

$10.69 /

-0.08 (-0.74%)

, INSM

Insmed

$36.75 /

+0.15 (+0.41%)

, IVC

Invacare

$8.90 /

+0.13 (+1.48%)

, IRWD

Ironwood

$11.48 /

+0.36 (+3.24%)

, KPTI

Karyopharm

$12.60 /

+0.045 (+0.36%)

, KYMR

Kymera Therapeutics

$59.95 /

-0.335 (-0.56%)

, LEGN

Legend Biotech

$26.15 /

+0.2 (+0.77%)

, PRLD

Prelude Therapeutics

$60.50 /

+1.66 (+2.82%)

, RDUS

Radius Health

$23.11 /

-0.09 (-0.39%)

, RGNX

Regenxbio

$41.78 /

+0.06 (+0.14%)

, RPTX

Repare Therapeutics

$28.50 /

-0.05 (-0.18%)

, SGTX

Sigilon Therapeutics

$26.49 /

+0.36 (+1.38%)

, TNDM

TNDM

/

+

, ZNTL

Zentalis

$44.66 /

-1.09 (-2.38%)

Healthcare Corporate…

Healthcare Corporate Access Virtual Day to be held on March 16.

ShowHide Related Items >><<
ZNTL Zentalis
$44.66 /

-1.09 (-2.38%)

TNDM TNDM
/

+

SGTX Sigilon Therapeutics
$26.49 /

+0.36 (+1.38%)

RGNX Regenxbio
$41.78 /

+0.06 (+0.14%)

RDUS Radius Health
$23.11 /

-0.09 (-0.39%)

PRLD Prelude Therapeutics
$60.50 /

+1.66 (+2.82%)

LEGN Legend Biotech
$26.15 /

+0.2 (+0.77%)

KYMR Kymera Therapeutics
$59.95 /

-0.335 (-0.56%)

KPTI Karyopharm
$12.60 /

+0.045 (+0.36%)

IVC Invacare
$8.90 /

+0.13 (+1.48%)

IRWD Ironwood
$11.48 /

+0.36 (+3.24%)

INSM Insmed
$36.75 /

+0.15 (+0.41%)

IMRA Imara
$10.69 /

-0.08 (-0.74%)

HAE Haemonetics
$118.72 /

-0.44 (-0.37%)

FUSN Fusion Pharmaceuticals
$11.70 /

-0.05 (-0.43%)

FULC Fulcrum Therapeutics
$11.91 /

-0.06 (-0.50%)

FHTX Foghorn Therapeutics
$12.71 /

+0.1 (+0.79%)

CABA Cabaletta Bio
$11.81 /

-0.01 (-0.08%)

AVRO Avrobio
$13.36 /

+0.34 (+2.61%)

ALEC Alector
$18.70 /

+0.05 (+0.27%)

ALEC Alector
$18.70 /

+0.05 (+0.27%)

01/15/21 BofA
Alector reinstated with a Buy at BofA
11/11/20 Citi
Alector price target lowered to $31 from $40 at Citi
06/24/20 H.C. Wainwright
Alector initiated with a Buy at H.C. Wainwright
04/28/20 Goldman Sachs
Alector initiated with a Buy at Goldman Sachs
AVRO Avrobio
$13.36 /

+0.34 (+2.61%)

03/10/21 Stifel
Stifel says Bluebird update on AML provides 'some relief' to other LV players
03/09/21 Barclays
Avrobio initiated with an Overweight at Barclays
03/01/21 Stifel
Avrobio initiated with a Hold at Stifel
02/17/21 Mizuho
Avrobio selloff on Bluebird news a buying opportunity, says Mizuho
BOLT Bolt Biotherapeutics
$39.81 /

+0.99 (+2.55%)

03/02/21
Fly Intel: Top five analyst initiations
03/02/21 SVB Leerink
Bolt Biotherapeutics initiated with an Outperform at SVB Leerink
03/02/21 Morgan Stanley
Bolt Biotherapeutics initiated with an Overweight at Morgan Stanley
03/02/21 Stifel
Bolt Biotherapeutics initiated with a Buy at Stifel
CABA Cabaletta Bio
$11.81 /

-0.01 (-0.08%)

01/08/21 Chardan
Cabaletta Bio initiated with a Buy at Chardan
10/13/20 H.C. Wainwright
Cabaletta Bio initiated with a Buy at H.C. Wainwright
FHTX Foghorn Therapeutics
$12.71 /

+0.1 (+0.79%)

11/17/20 Morgan Stanley
Foghorn Therapeutics initiated with an Overweight at Morgan Stanley
11/17/20 Wedbush
Wedbush bullish on Foghorn Therapeutics, initiates with an Outperform
11/17/20 Wedbush
Foghorn Therapeutics initiated with an Outperform at Wedbush
11/17/20 Cowen
Foghorn Therapeutics initiated with an Outperform at Cowen
FULC Fulcrum Therapeutics
$11.91 /

-0.06 (-0.50%)

03/04/21 Piper Sandler
Fulcrum Therapeutics price target lowered to $20 from $22 at Piper Sandler
03/01/21 Stifel
Fulcrum Therapeutics initiated with a Buy at Stifel
10/15/20 Piper Sandler
Fulcrum Therapeutics initiated with an Overweight at Piper Sandler
08/12/20
Fly Intel: Top five analyst downgrades
FUSN Fusion Pharmaceuticals
$11.70 /

-0.05 (-0.43%)

07/21/20
Fly Intel: Top five analyst initiations
07/21/20 Morgan Stanley
Fusion Pharmaceuticals initiated with an Overweight at Morgan Stanley
07/21/20 Wedbush
Wedbush bullish on Fusion Pharmaceuticals, initiates with an Outperform
07/21/20 Jefferies
Fusion Pharmaceuticals initiated with a Buy at Jefferies
HAE Haemonetics
$118.72 /

-0.44 (-0.37%)

02/03/21 Barrington
Haemonetics upgraded to Outperform from Market Perform at Barrington
01/21/21 Barrington
Haemonetics downgraded to Market Perform from Outperform at Barrington
01/21/21 JMP Securities
Haemonetics price target raised to $140 from $110 at JMP Securities
11/05/20 Barrington
Haemonetics upgraded to Outperform from Market Perform at Barrington
IMRA Imara
$10.69 /

-0.08 (-0.74%)

03/08/21 SVB Leerink
Imara price target lowered to $42 from $59 at SVB Leerink
01/06/21 SVB Leerink
Imara selloff a potential buying opportunity, says SVB Leerink
08/17/20
Fly Intel: Top five analyst upgrades
08/17/20 Citi
Imara upgraded to Buy from Neutral at Citi
INSM Insmed
$36.75 /

+0.15 (+0.41%)

02/22/21 Credit Suisse
United Therapeutics price target raised to $196 from $169 at Credit Suisse
01/19/21 Credit Suisse
Insmed price target raised to $60 from $50 at Credit Suisse
12/17/20 Berenberg
Insmed initiated with a Buy at Berenberg
11/23/20 Evercore ISI
Insmed resumed with an Outperform at Evercore ISI
IVC Invacare
$8.90 /

+0.13 (+1.48%)

IRWD Ironwood
$11.48 /

+0.36 (+3.24%)

02/09/21 Gordon Haskett
Ironwood odds of sale improved with CEO exit, says Gordon Haskett
11/06/20 Wells Fargo
Ironwood rally 'looks like a kneejerk overreaction,' says Wells Fargo
09/30/20
Fly Intel: Top five analyst downgrades
09/30/20 Wells Fargo
Ironwood downgraded to Equal Weight at Wells Fargo after pipeline miss
KPTI Karyopharm
$12.60 /

+0.045 (+0.36%)

02/12/21 Barclays
Karyopharm price target lowered to $22 from $26 at Barclays
02/01/21 Barclays
Karyopharm price target lowered to $26 from $31 at Barclays
12/11/20 RBC Capital
Karyopharm's NCCN inclusion should benefit uptake of Xpovio, says RBC Capital
09/25/20 RBC Capital
Karyopharm shares undervalued as seli moves into MF, says RBC Capital
KYMR Kymera Therapeutics
$59.95 /

-0.335 (-0.56%)

03/02/21 Piper Sandler
Kymera Therapeutics plans to file two INDs in 2H21, says Piper Sandler
02/05/21 Piper Sandler
Piper reiterates Overweight on Kymera after Sanofi capital markets day
12/04/20 H.C. Wainwright
Kymera Therapeutics initiated with a Buy at H.C. Wainwright
11/24/20 Morgan Stanley
Kymera Therapeutics price target raised to $45 from $27 at Morgan Stanley
LEGN Legend Biotech
$26.15 /

+0.2 (+0.77%)

07/01/20 JPMorgan
Legend Biotech initiated with an Overweight at JPMorgan
07/01/20 Jefferies
Legend Biotech initiated with a Buy at Jefferies
06/30/20 Morgan Stanley
Legend Biotech initiated with an Overweight at Morgan Stanley
PRLD Prelude Therapeutics
$60.50 /

+1.66 (+2.82%)

11/20/20 BofA
Prelude Therapeutics downgraded to Neutral from Buy at BofA
11/20/20 BofA
Prelude Therapeutics downgraded to Neutral from Buy at BofA
10/20/20
Fly Intel: Top five analyst initiations
10/20/20 Morgan Stanley
Prelude Therapeutics initiated with an Equal Weight at Morgan Stanley
RDUS Radius Health
$23.11 /

-0.09 (-0.39%)

02/24/21 H.C. Wainwright
Radius Health price target raised to $25 from $22 at H.C. Wainwright
01/07/21 Citi
Radius Health price target raised to $30 from $25 at Citi
10/22/20 H.C. Wainwright
Radius Health price target lowered to $22 from $28 at H.C. Wainwright
09/29/20 JPMorgan
Radius Health resumed with a Neutral at JPMorgan
RGNX Regenxbio
$41.78 /

+0.06 (+0.14%)

02/09/21 Morgan Stanley
Sarepta denied motion to dismiss 'Wilson Wolf' case, says Morgan Stanley
01/20/21 RBC Capital
Regenxbio price target raised to $50 from $42 at RBC Capital
01/06/21 Chardan
Regenxbio named top 2021 pick with $100 target at Chardan
01/06/21 Raymond James
Regenxbio upgraded to Strong Buy from Outperform at Raymond James
RPTX Repare Therapeutics
$28.50 /

-0.05 (-0.18%)

03/01/21 Berenberg
Repare Therapeutics initiated with a Buy at Berenberg
12/29/20 Northland
Northland ups Repare Therapeutics price target to $42, calls a Top Pick for 2021
10/28/20
Fly Intel: Top five analyst initiations
10/28/20 Northland
Repare Therapeutics initiated with an Outperform at Northland
SGTX Sigilon Therapeutics
$26.49 /

+0.36 (+1.38%)

12/29/20 Barclays
Sigilon Therapeutics initiated with an Overweight at Barclays
12/29/20 Morgan Stanley
Sigilon Therapeutics initiated with an Equal Weight at Morgan Stanley
12/29/20 Jefferies
Sigilon Therapeutics initiated with a Buy at Jefferies
TNDM TNDM
/

+

03/12/21 Piper Sandler
Tandem Diabetes competition concerns overblown, says Piper Sandler
02/25/21 Lake Street
Tandem Diabetes price target raised to $150 from $137 at Lake Street
02/04/21 Piper Sandler
Tandem trades at 'significant discount' to Insulet, says Piper Sandler
01/21/21 Citi
Citi adds Tandem, removes Guardant from 'Value Creators' list
ZNTL Zentalis
$44.66 /

-1.09 (-2.38%)

01/19/21 Wedbush
Zentalis initiated with an Outperform at Wedbush
09/28/20 Cantor Fitzgerald
Cantor starts 'underappreciated' Zentalis with Overweight, $44 target
09/28/20 Cantor Fitzgerald
Zentalis initiated with an Overweight at Cantor Fitzgerald
08/27/20 H.C. Wainwright
Zentalis initiated with a Buy at H.C. Wainwright
ZNTL Zentalis
$44.66 /

-1.09 (-2.38%)

TNDM TNDM
/

+

RPTX Repare Therapeutics
$28.50 /

-0.05 (-0.18%)

RGNX Regenxbio
$41.78 /

+0.06 (+0.14%)

RDUS Radius Health
$23.11 /

-0.09 (-0.39%)

PRLD Prelude Therapeutics
$60.50 /

+1.66 (+2.82%)

LEGN Legend Biotech
$26.15 /

+0.2 (+0.77%)

KYMR Kymera Therapeutics
$59.95 /

-0.335 (-0.56%)

KPTI Karyopharm
$12.60 /

+0.045 (+0.36%)

IVC Invacare
$8.90 /

+0.13 (+1.48%)

IRWD Ironwood
$11.48 /

+0.36 (+3.24%)

INSM Insmed
$36.75 /

+0.15 (+0.41%)

IMRA Imara
$10.69 /

-0.08 (-0.74%)

HAE Haemonetics
$118.72 /

-0.44 (-0.37%)

FULC Fulcrum Therapeutics
$11.91 /

-0.06 (-0.50%)

FHTX Foghorn Therapeutics
$12.71 /

+0.1 (+0.79%)

CABA Cabaletta Bio
$11.81 /

-0.01 (-0.08%)

AVRO Avrobio
$13.36 /

+0.34 (+2.61%)

ALEC Alector
$18.70 /

+0.05 (+0.27%)

  • 05
    Feb
  • 20
    Jan
  • 08
    Jan
  • 07
    Jan
  • 04
    Dec
  • 20
    Nov
  • 23
    Oct
  • 25
    Sep
  • 21
    Aug
  • 30
    Jul
  • 15
    Jul
  • 26
    Jun
  • 19
    Jun
  • 05
    Jun
  • 05
    May
  • 03
    Apr
IRWD Ironwood
$11.48 /

+0.36 (+3.24%)

SGTX Sigilon Therapeutics
$26.49 /

+0.36 (+1.38%)

RGNX Regenxbio
$41.78 /

+0.06 (+0.14%)

PRLD Prelude Therapeutics
$60.50 /

+1.66 (+2.82%)

LEGN Legend Biotech
$26.15 /

+0.2 (+0.77%)

KPTI Karyopharm
$12.60 /

+0.045 (+0.36%)

IRWD Ironwood
$11.48 /

+0.36 (+3.24%)

IMRA Imara
$10.69 /

-0.08 (-0.74%)

FHTX Foghorn Therapeutics
$12.71 /

+0.1 (+0.79%)

BOLT Bolt Biotherapeutics
$39.81 /

+0.99 (+2.55%)

AVRO Avrobio
$13.36 /

+0.34 (+2.61%)

LEGN Legend Biotech
$26.15 /

+0.2 (+0.77%)

CABA Cabaletta Bio
$11.81 /

-0.01 (-0.08%)

Hot Stocks
Invacare falls -20.1% » 12:00
03/11/21
03/11
12:00
03/11/21
12:00
IVC

Invacare

$7.95 /

-2.02 (-20.26%)

Invacare is down -20.1%,…

Invacare is down -20.1%, or -$2.00 to $7.96.

ShowHide Related Items >><<
IVC Invacare
$7.95 /

-2.02 (-20.26%)

IVC Invacare
$7.95 /

-2.02 (-20.26%)

Hot Stocks
Invacare falls -16.8% » 10:00
03/11/21
03/11
10:00
03/11/21
10:00
IVC

Invacare

$8.21 /

-1.76 (-17.65%)

Invacare is down -16.8%,…

Invacare is down -16.8%, or -$1.67 to $8.29.

ShowHide Related Items >><<
IVC Invacare
$8.21 /

-1.76 (-17.65%)

IVC Invacare
$8.21 /

-1.76 (-17.65%)

Hot Stocks
Invacare falls -10.6% » 09:47
03/11/21
03/11
09:47
03/11/21
09:47
IVC

Invacare

$8.77 /

-1.2 (-12.04%)

Invacare is down -10.6%,…

Invacare is down -10.6%, or -$1.06 to $8.90.

ShowHide Related Items >><<
IVC Invacare
$8.77 /

-1.2 (-12.04%)

IVC Invacare
$8.77 /

-1.2 (-12.04%)

Earnings
Invacare sees FY21 constant currency net sales growth of 4%-7% » 16:15
02/10/21
02/10
16:15
02/10/21
16:15
IVC

Invacare

$10.45 /

-0.15 (-1.42%)

Invacare said:…

Invacare said: "Based on expectations of continued progress in the company's performance, increased visibility into the path of recovery for its customers, expected improvement in access to healthcare, improvements to global pandemic-related supply chain disruptions, and pent-up demand from the prior year, the company expects operating results for the full year 2021 consisting of: Constant currency net sales growth in the range of 4% to 7%; Adjusted EBITDA improvement of 41%, to $45 million; and, Free cash flow of $5 million. The company participates in durable healthcare markets and serves a persistent need for its products. The company expects to grow full-year revenue by effectively engaging with customers interested in its broad portfolio and new products. However, public health restrictions currently in place, especially severely in Europe, may result in net sales in the first quarter to be down slightly to mid-single digits as compared to the prior year, which was not impacted by the pandemic. The company will continue to improve operating efficiency, together with the lifting of public health restrictions, yielding improved financial performance. As a result, the company expects to grow revenue, profitability, and free cash flow in the year."

ShowHide Related Items >><<
IVC Invacare
$10.45 /

-0.15 (-1.42%)

IVC Invacare
$10.45 /

-0.15 (-1.42%)

Earnings
Invacare reports Q4 adjusted EPS (10c), consensus (20c) » 16:14
02/10/21
02/10
16:14
02/10/21
16:14
IVC

Invacare

$10.45 /

-0.15 (-1.42%)

Reports Q4 revenue…

Reports Q4 revenue $224.0M, consensus $215.58M. Matt Monaghan, chairman, president and CEO, said: "Looking ahead, we expect revenue growth from our full offering of recently launched products and the pipeline of more new products launching in 2021. We anticipate pent-up demand for mobility and seating products to support sales growth in the future as public health restrictions diminish. In addition, the German plant consolidation completed in 2020, and the ongoing IT modernization program, will simplify how we do business and generate sustainable growth, long-term profit and shareholder value. While we could not have predicted the pandemic that tested the resolve of our customers, suppliers, associates and people who rely on our products every day, I am incredibly proud of all we accomplished."

ShowHide Related Items >><<
IVC Invacare
$10.45 /

-0.15 (-1.42%)

IVC Invacare
$10.45 /

-0.15 (-1.42%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.